https://www.selleckchem.com/products/ABT-263.html
To investigate and study the therapeutic effect of DRCOP regimen based on polyethylene glycol liposome doxorubicin (PLD) on patients with diffuse large B cell lymphoma (DLBCL). A retrospective analysis was conducted on 80 patients with DLBCL admitted to our hospital from June 2016 to June 2017, and the patients were equally and randomly divided into the experimental and the control group. Patients in the experimental group were treated with the DRCOP regimen based on PLD, and the patients in the control group were treated with the tradi
Like
Comment
Share
